← Back to KPRX

Kiora Pharmaceuticals, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 07/08/2026Mar 2026Filed 08/05/2026Sep 2025Filed 07/11/2025Jun 2025Filed 07/08/2026Mar 2025Filed 08/05/2026Sep 2024Filed 07/11/2025Jun 2024Filed 08/08/2025Mar 2024Filed 09/05/2025
$0$0$0$0$0$16
−$2.1−$2.4$0−$2.2−$2.2−$3.4−$2.2$13
−$0.34−$0.58$0.01−$0.54−$0.52−$0.81−$0.53$3.46
6.24.24.444.24.24.23.9

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.